Skip to Content
Merck
  • Characterization of a mutant T-cell hybridoma line with defects in the TCR-mediated apoptotic pathway.

Characterization of a mutant T-cell hybridoma line with defects in the TCR-mediated apoptotic pathway.

Cell death and differentiation (1999-04-14)
G Morgan, S Smith, J Pak, A Marshak-Rothstein, R Fissore, B Osborne
ABSTRACT

A mutant T-cell hybridoma line named mutant 51 was developed that, unlike the parental line, did not die after T-cell receptor (TCR) engagement and demonstrated reduced death in response to dexamethasone. Intracellular calcium measurements showed that available calcium stores were markedly reduced in the mutant cell line. Unlike control cells, secretion of IL-2 from mutant cells was also greatly reduced, although addition of exogenous IL-2 did not facilitate increased apoptosis. Although levels of the cell death gene product Nur77 were equivalent, additional studies showed that mutant cells expressed Nur77 predominantly in the cytoplasm following TCR engagement, while parental cells displayed a nuclear translocalization of Nur77. In addition, Fas levels and Fas ligand dependant killing were both markedly reduced in the mutant clone. From these data we hypothesize a role for available calcium stores and Nur77 nuclear localization in TCR-mediated apoptosis in T-cell hybridomas.